Literature DB >> 2213811

Pyoderma gangrenosum with severe pharyngeal ulceration.

C Buckley1, A H Bayoumi, I Sarkany.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213811      PMCID: PMC1292823          DOI: 10.1177/014107689008300918

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  7 in total

1.  Stomal ulceration associated with pyoderma gangrenosum and chronic ulcerative colitis. Report of two cases.

Authors:  J S MARGOLES; J WENGER
Journal:  Gastroenterology       Date:  1961-12       Impact factor: 22.682

2.  [Peristomal pyoderma gangrenosum].

Authors:  F Allegue Rodriguez; A Marques Huberti; P Freire Murgueytio; A Ledo Pozueta
Journal:  Ann Dermatol Venereol       Date:  1988       Impact factor: 0.777

3.  Pyoderma gangrenosum associated with Behçet's syndrome--response to thalidomide.

Authors:  C S Munro; N H Cox
Journal:  Clin Exp Dermatol       Date:  1988-11       Impact factor: 3.470

4.  Pyoderma gangrenosum involving the head and neck.

Authors:  M S Yco; G R Warnock; J C Cruickshank; J R Burnett
Journal:  Laryngoscope       Date:  1988-07       Impact factor: 3.325

5.  Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis.

Authors:  G S Lazarus; L A Goldsmith; R E Rocklin; R S Pinals; J P de Buisseret; J R David
Journal:  Arch Dermatol       Date:  1972-01

6.  Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine.

Authors:  L Brandt; I Gärtner; P G Nilsson; T Olofsson
Journal:  Acta Med Scand       Date:  1977-01

7.  Pyoderma gangrenosum of the oral cavity, nose, and larynx.

Authors:  K S Kennedy; M L Prendergast; C D Sooy
Journal:  Otolaryngol Head Neck Surg       Date:  1987-11       Impact factor: 3.497

  7 in total
  3 in total

Review 1.  Oral Pyoderma Gangrenosum: Diagnosis, Treatment and Challenges: A Systematic Review.

Authors:  Caroline Bissonnette; Adel Kauzman; Gisele N Mainville
Journal:  Head Neck Pathol       Date:  2017-03-08

Review 2.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

3.  Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case.

Authors:  Umit Yavuz Malkan; Gursel Gunes; Eylem Eliacik; Ibrahim Celalettin Haznedaroglu
Journal:  Int Med Case Rep J       Date:  2016-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.